Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695490016 | Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3695492012 | Rotigotine 250 microgram/hour prolonged-release transdermal patch | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Is a | Rotigotine only product in transdermal dose form | true | Inferred relationship | Some | ||
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Is a | Rotigotine-containing product in transdermal dose form | false | Inferred relationship | Some | ||
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has BoSS | Rotigotine | true | Inferred relationship | Some | 1 | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has manufactured dose form | Prolonged-release transdermal patch | true | Inferred relationship | Some | ||
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has concentration strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has concentration strength denominator unit | hour | true | Inferred relationship | Some | 1 | |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | Has precise active ingredient | Rotigotine | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR